To obtain the most beneficial result from our service for patients diagnosed with cancerous malformations, we recommend contacting your oncologist before ordering. In case of any remaining questions, we can also provide the information you might need to know about the technology and the benefits you can obtain from the results of the test. We also believe that every cancer has a specific code, and this information can be cracked with the help of our service to select the most promising strategy for efficient cancer treatment.

We also recommend checking the following list for successful application:

• The malignant transformation should be diagnosed by a medical expert.
• The cancer should be validated by a molecular pathologist.
• We also suggest contacting us if a similar test has already been performed.
• Our service is highly recommended for patients who are seeking the most valuable cancer treatment.

During the assay selection, please consider the minimum genes and genomic positions required for the identification of clinically relevant FDA-approved therapies. Our webpage provides the necessary information for the decision making; although if further information is necessary, use our form to contact us. The pathogenic mutations and gene expression changes targeted by our panels are used as prognostic biomarkers to support the clinicians in the process of decision making. Because these genes and variants will change as the literature and drug indications evolve, we regularly update our AI-based decision making protocol to provide the patients the most promising results.